HOLDRS Biotech

"Final" End of Day ETF Report for 3/12/10

Data Period (Except as noted, statistics reflect the most current day's trading) Daily Weekly Monthly Quarterly
Open 104.61 103.68 102.89 98.18
High 104.61 104.74 104.74 104.74
Low 103.70 103.35 102.12 96.89
Close 104.21 104.21 104.21 104.21
Net change since last period end through current day 0.08 0.48 2.08 6.67
Net change of previous completed period -0.17 1.60 -0.39 -4.04
         
Volume 305 2,848 4,644 29,352
Total Volume of Component Issues 262,588 1,386,826 2,933,146 16,815,571
         
1 Year Price High 176.50 176.50 176.50 177.69  
1 Year Price High Date 3/27/09 3/27/09 3/31/09 3/31/09
1 Year Price Low 84.55 84.55 84.55 84.55
1 Year Price Low Date 4/20/09 4/24/09 4/30/09 6/30/09
         
Trend Pivot 103.34 100.50 131.81 142.68
Current Trend Up Up Down Down
      Trend Gain/Loss as of Period End 2.08 4.79 -15.59 -11.15
      Trend Life (Periods) 10 9 11 3
      Trend Begin Date 2/26/10 1/8/10 4/30/09 6/30/09
         
         
         
Composite Statistics  
       
      % Of Component Issues In Uptrends 83.33% 100.00% 83.33% 50.00%
      Total Up Trends 10 12 10 6
            New Up Trends 0 1 1 0
      Total Down Trends 2 0 2 6
            New Down Trends 1 0 0 1
         
      Component Issues Traded 12 12 12 12
      % Of Component Issues Advancing 41.67% 75.00% 83.33% 83.33%
      Advancing Issues 5 9 10 10
      Declining Issues 7 3 2 2
      Unchanged Issues 0 0 0 0
      % Advancing Volume 49.03% 62.87% 65.89% 97.36%
      Advancing Volume 128,743 871,900 1,932,626 16,371,545
      Declining Volume 133,845 514,926 1,000,520 444,026
      Unchanged Volume 0 0 0 0
         
      New Component 1 Year Highs 1 3 4 6
      New Component 1 Year Lows 0 0 0 0
         
      Component Issues Above/Below Period Moving Average        
     

     

% Above 200 Period Moving Average 100.00% 66.67% 75.00% 100.00%
                  Issues Above 12 8 9 12
                  Issues Below 0 4 3 0
     

     

% Above 50 Period Moving Average 100.00% 100.00% 50.00% 66.67%
                  Issues Above 12 12 6 8
                  Issues Below 0 0 6 4
     

     

% Above 30 Period Moving Average 100.00% 91.67% 66.67% 50.00%
                  Issues Above 12 11 8 6
                  Issues Below 0 1 4 6
     

     

% Above 18 Period Moving Average 91.67% 91.67% 83.33% 50.00%
                  Issues Above 11 11 10 6
                  Issues Below 1 1 2 6
     

     

% Above 9 Period Moving Average 75.00% 100.00% 91.67% 66.67%
                  Issues Above 9 12 11 8
                  Issues Below 3 0 1 4
     

     

% Above 4 Period Moving Average 58.33% 91.67% 100.00% 100.00%
                  Issues Above 7 11 12 12
                  Issues Below 5 1 0 0
         
 

Components

Trend As Of Period End

Data Period (Except as noted, statistics reflect the most current day's trading) Daily Weekly Monthly Quarterly
HOLDRS Biotech (BBH) 2/26/10 1/8/10 4/30/09 6/30/09
Affymetrix Inc (AFFX) 3/12/10   2/5/10 2/26/10 3/31/06
Alkermes Inc. (ALKS) 2/26/10 12/4/09 1/29/10 12/31/07
Amgen Inc (AMGN) 3/3/10 1/29/10 3/12/10   3/31/09
Biogen Idec Inc (BIIB) 2/26/10 12/4/09 12/31/09 9/30/09
Applera Corp-Celera Genomics (CRA.O) 3/10/10 3/5/10 10/31/08 12/31/08
Enzon Pharmaceuticals Inc. (ENZN) 3/1/10 3/12/10   9/30/09 6/30/09
Genzyme General (GENZ) 2/11/10 1/8/10 11/28/08 12/31/08
Gilead Sciences Inc. (GILD) 3/8/10 1/15/10 1/29/10 12/31/98
Human Genome Sciences Inc. (HGSI)   2/11/10 3/5/10 7/31/09 9/30/09
Life Technologies Corporation (LIFE) 2/12/10 2/19/10 4/30/09 6/30/09
QLT Inc. (QLTI) 2/11/10 11/27/09 7/31/09 3/12/10  
Shire Pharmaceuticals Group plc (SHPGY) 2/11/10 5/22/09 8/31/09 9/30/09
 
    
   
 
   
   
   

 


MasterDATA - the only source for Index and ETF composite breadth historical data, charts and reports - Home


www.masterdata.com
support@masterdata.com


Disclaimer: This material is for your private information. We are not soliciting any action based upon it. Opinions expressed are present opinions only. The material is based upon information considered reliable, but we do not represent that is accurate or complete, and it should not be relied upon as such. We, or persons involved in the preparation or issuance of this material may, from time to time, have long or short positions in, and buy or sell the securities or options of companies mentioned herein.